PLX Operating Expenses
Protalix Biotherapeutics Inc · Operating Expenses
PLX Operating Expenses
Latest reported$32.50Mperiod ending
PLX TTM Operating Expenses ($630.00K → $32.50M)
TTM operating expenses
High-resolution chart · PNG
PLX operating expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Expenses (USD) |
|---|---|
| 32,496,000 | |
| 33,650,000 | |
| 31,251,000 | |
| 29,213,000 | |
| 27,410,000 | |
| 25,239,000 | |
| 25,163,000 | |
| 25,285,000 | |
| 27,031,000 | |
| 29,092,000 | |
| 32,052,000 | |
| 33,522,000 | |
| 36,417,000 | |
| 38,101,000 | |
| 41,060,000 | |
| 43,452,000 | |
| 43,454,000 | |
| 44,124,000 | |
| 42,463,000 | |
| 45,260,000 | |
| 45,528,000 | |
| 46,048,000 | |
| 49,315,000 | |
| 48,020,000 | |
| 50,103,000 | |
| 54,114,000 | |
| 54,515,000 | |
| 55,103,000 | |
| 55,957,000 | |
| 49,965,000 | |
| 44,978,000 | |
| 44,114,000 | |
| 39,898,000 | |
| 42,139,000 | |
| 40,364,000 | |
| 36,880,000 | |
| 34,725,000 | |
| 33,110,000 | |
| 33,964,000 | |
| 31,523,000 | |
| 30,760,000 | |
| 29,298,000 | |
| 29,953,000 | |
| 30,433,000 | |
| 32,243,000 | |
| 30,208,000 | |
| 31,311,000 | |
| 34,141,000 | |
| 33,441,000 | |
| 35,553,000 | |
| 33,201,000 | |
| 32,520,000 | |
| 33,686,000 | |
| 37,405,000 | |
| 38,452,000 | |
| 38,567,000 | |
| 39,428,000 | |
| 41,569,000 | |
| 43,356,000 | |
| 37,130,000 | |
| 32,653,000 | |
| 29,444,000 | |
| 28,445,000 | |
| 37,347,000 | |
| 38,426,000 | |
| 33,008,000 | |
| 28,782,000 | |
| 23,246,000 | |
| 23,918,000 | |
| 22,943,000 | |
| 24,171,000 | |
| 21,189,000 | |
| 20,902,000 | |
| 25,339,000 | |
| 22,857,000 | |
| 29,153,000 | |
| 25,259,000 | |
| 15,950,112 | |
| 12,190,223 | |
| 2,610,324 | |
| 109,209 | |
| 103,542 | |
| 93,294 | |
| 99,300 | |
| 107,297 | |
| 146,760 | |
| 165,581 | |
| 182,329 | |
| 171,465 | |
| 142,518 | |
| 147,385 | |
| 151,062 | |
| 153,804 | |
| 159,718 | |
| 165,790 | |
| 269,502 | |
| 292,415 | |
| 320,588 | |
| 385,789 | |
| 449,838 |